ipilimumabPublished on: 16 Apr 2018
Improved PFS with nivo + ipi in patients with advanced NSCLC with high TMB
Patients with newly diagnosed advanced NSCLC with high tumor mutational burden had significantly improved PFS with nivolumab plus ipilimumab.
